Annual Revenue
$106.34 M
+$8.39 M+8.57%
December 31, 2023
Summary
- As of February 10, 2025, LAB annual revenue is $106.34 million, with the most recent change of +$8.39 million (+8.57%) on December 31, 2023.
- During the last 3 years, LAB annual revenue has fallen by -$31.80 million (-23.02%).
- LAB annual revenue is now -23.02% below its all-time high of $138.14 million, reached on December 31, 2020.
Performance
LAB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$44.97 M
+$7.76 M+20.87%
September 30, 2024
Summary
- As of February 10, 2025, LAB quarterly revenue is $44.97 million, with the most recent change of +$7.76 million (+20.87%) on September 30, 2024.
- Over the past year, LAB quarterly revenue has increased by +$16.78 million (+59.53%).
- LAB quarterly revenue is now -1.25% below its all-time high of $45.54 million, reached on March 31, 2024.
Performance
LAB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$155.90 M
+$19.60 M+14.38%
September 30, 2024
Summary
- As of February 10, 2025, LAB TTM revenue is $155.90 million, with the most recent change of +$19.60 million (+14.38%) on September 30, 2024.
- Over the past year, LAB TTM revenue has increased by +$49.56 million (+46.61%).
- LAB TTM revenue is now at all-time high.
Performance
LAB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
LAB Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.6% | +59.5% | +46.6% |
| 3 y3 years | -23.0% | +62.5% | +47.8% |
| 5 y5 years | -5.9% | +62.5% | +47.8% |
LAB Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.6% | +8.6% | -1.3% | +139.5% | at high | +61.5% |
| 5 y | 5-year | -23.0% | +8.6% | -1.3% | +139.5% | at high | +61.5% |
| alltime | all time | -23.0% | +1562.1% | -1.3% | +569.6% | at high | +1945.2% |
Standard BioTools Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $44.97 M(+20.9%) | $155.90 M(+14.4%) |
| Jun 2024 | - | $37.20 M(-18.3%) | $136.30 M(+7.5%) |
| Mar 2024 | - | $45.54 M(+61.6%) | $126.76 M(+19.2%) |
| Dec 2023 | $106.34 M(+8.6%) | $28.19 M(+11.1%) | $106.34 M(+1.1%) |
| Sep 2023 | - | $25.37 M(-8.3%) | $105.17 M(-0.3%) |
| Jun 2023 | - | $27.67 M(+10.1%) | $105.45 M(+9.2%) |
| Mar 2023 | - | $25.12 M(-7.0%) | $96.56 M(-1.4%) |
| Dec 2022 | $97.95 M(-25.0%) | $27.02 M(+5.4%) | $97.95 M(-10.3%) |
| Sep 2022 | - | $25.65 M(+36.6%) | $109.19 M(-2.6%) |
| Jun 2022 | - | $18.78 M(-29.2%) | $112.05 M(-9.8%) |
| Mar 2022 | - | $26.50 M(-30.7%) | $124.29 M(-4.8%) |
| Dec 2021 | $130.58 M(-5.5%) | $38.27 M(+34.2%) | $130.58 M(-4.6%) |
| Sep 2021 | - | $28.50 M(-8.1%) | $136.92 M(-7.7%) |
| Jun 2021 | - | $31.02 M(-5.4%) | $148.28 M(+3.5%) |
| Mar 2021 | - | $32.79 M(-26.5%) | $143.32 M(+3.7%) |
| Dec 2020 | $138.14 M(+17.8%) | - | - |
| Dec 2020 | - | $44.61 M(+11.9%) | $138.14 M(+9.7%) |
| Sep 2020 | - | $39.86 M(+53.0%) | $125.98 M(+11.9%) |
| Jun 2020 | - | $26.06 M(-5.6%) | $112.61 M(-1.9%) |
| Mar 2020 | - | $27.62 M(-14.9%) | $114.75 M(-2.1%) |
| Dec 2019 | $117.24 M(+3.8%) | - | - |
| Dec 2019 | - | $32.44 M(+22.4%) | $117.24 M(+0.1%) |
| Sep 2019 | - | $26.50 M(-6.0%) | $117.13 M(-2.1%) |
| Jun 2019 | - | $28.20 M(-6.4%) | $119.59 M(+1.5%) |
| Mar 2019 | - | $30.11 M(-6.8%) | $117.83 M(+4.3%) |
| Dec 2018 | $112.96 M(+10.8%) | $32.33 M(+11.6%) | $112.96 M(+4.2%) |
| Sep 2018 | - | $28.96 M(+9.6%) | $108.38 M(+4.0%) |
| Jun 2018 | - | $26.43 M(+4.7%) | $104.17 M(+2.5%) |
| Mar 2018 | - | $25.25 M(-9.0%) | $101.65 M(-0.3%) |
| Dec 2017 | $101.94 M | $27.74 M(+12.1%) | $101.94 M(+2.7%) |
| Sep 2017 | - | $24.75 M(+3.5%) | $99.28 M(+2.6%) |
| Jun 2017 | - | $23.91 M(-6.3%) | $96.72 M(-4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $25.53 M(+1.8%) | $100.98 M(-3.3%) |
| Dec 2016 | $104.45 M(-8.9%) | $25.08 M(+13.0%) | $104.45 M(-5.1%) |
| Sep 2016 | - | $22.19 M(-21.2%) | $110.08 M(-5.5%) |
| Jun 2016 | - | $28.17 M(-2.9%) | $116.54 M(-0.4%) |
| Mar 2016 | - | $29.00 M(-5.6%) | $116.99 M(+2.0%) |
| Dec 2015 | $114.71 M(-1.5%) | $30.72 M(+7.3%) | $114.71 M(-2.4%) |
| Sep 2015 | - | $28.64 M(+0.1%) | $117.48 M(-0.8%) |
| Jun 2015 | - | $28.62 M(+7.1%) | $118.47 M(+0.9%) |
| Mar 2015 | - | $26.73 M(-20.2%) | $117.46 M(+0.9%) |
| Dec 2014 | $116.46 M(+63.6%) | $33.49 M(+13.0%) | $116.46 M(+12.1%) |
| Sep 2014 | - | $29.64 M(+7.3%) | $103.85 M(+12.3%) |
| Jun 2014 | - | $27.61 M(+7.3%) | $92.50 M(+12.3%) |
| Mar 2014 | - | $25.72 M(+23.2%) | $82.37 M(+15.7%) |
| Dec 2013 | $71.18 M(+36.0%) | $20.88 M(+14.2%) | $71.18 M(+7.9%) |
| Sep 2013 | - | $18.29 M(+4.6%) | $65.96 M(+9.1%) |
| Jun 2013 | - | $17.48 M(+20.3%) | $60.46 M(+8.1%) |
| Mar 2013 | - | $14.54 M(-7.2%) | $55.92 M(+6.9%) |
| Dec 2012 | $52.33 M(+22.1%) | $15.66 M(+22.5%) | $52.33 M(+5.4%) |
| Sep 2012 | - | $12.78 M(-1.3%) | $49.67 M(+4.6%) |
| Jun 2012 | - | $12.95 M(+18.3%) | $47.48 M(+5.3%) |
| Mar 2012 | - | $10.95 M(-15.8%) | $45.11 M(+5.2%) |
| Dec 2011 | $42.87 M(+27.7%) | $13.00 M(+22.7%) | $42.87 M(+6.6%) |
| Sep 2011 | - | $10.60 M(+0.2%) | $40.22 M(+5.6%) |
| Jun 2011 | - | $10.58 M(+21.6%) | $38.09 M(+7.2%) |
| Mar 2011 | - | $8.70 M(-16.0%) | $35.54 M(+5.9%) |
| Dec 2010 | $33.56 M(+32.1%) | $10.36 M(+22.3%) | $33.56 M(+8.9%) |
| Sep 2010 | - | $8.47 M(+5.5%) | $30.83 M(+37.9%) |
| Jun 2010 | - | $8.02 M(+19.5%) | $22.36 M(+56.0%) |
| Mar 2010 | - | $6.72 M(-11.9%) | $14.34 M(+88.1%) |
| Dec 2009 | $25.41 M(+65.6%) | $7.62 M | $7.62 M |
| Dec 2008 | $15.35 M(+111.0%) | - | - |
| Dec 2007 | $7.28 M(+13.7%) | - | - |
| Dec 2006 | $6.40 M | - | - |
FAQ
- What is Standard BioTools annual revenue?
- What is the all time high annual revenue for Standard BioTools?
- What is Standard BioTools annual revenue year-on-year change?
- What is Standard BioTools quarterly revenue?
- What is the all time high quarterly revenue for Standard BioTools?
- What is Standard BioTools quarterly revenue year-on-year change?
- What is Standard BioTools TTM revenue?
- What is the all time high TTM revenue for Standard BioTools?
- What is Standard BioTools TTM revenue year-on-year change?
What is Standard BioTools annual revenue?
The current annual revenue of LAB is $106.34 M
What is the all time high annual revenue for Standard BioTools?
Standard BioTools all-time high annual revenue is $138.14 M
What is Standard BioTools annual revenue year-on-year change?
Over the past year, LAB annual revenue has changed by +$8.39 M (+8.57%)
What is Standard BioTools quarterly revenue?
The current quarterly revenue of LAB is $44.97 M
What is the all time high quarterly revenue for Standard BioTools?
Standard BioTools all-time high quarterly revenue is $45.54 M
What is Standard BioTools quarterly revenue year-on-year change?
Over the past year, LAB quarterly revenue has changed by +$16.78 M (+59.53%)
What is Standard BioTools TTM revenue?
The current TTM revenue of LAB is $155.90 M
What is the all time high TTM revenue for Standard BioTools?
Standard BioTools all-time high TTM revenue is $155.90 M
What is Standard BioTools TTM revenue year-on-year change?
Over the past year, LAB TTM revenue has changed by +$49.56 M (+46.61%)